))
Ep. 13: Edward Lanphier, chief editing officer
Manage episode 337513031 series 3382327
Indhold leveret af GuidePost and The CRISPR Journal. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af GuidePost and The CRISPR Journal eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.
The recently retired founding CEO of Sangamo Therapeutics, Edward Lanphier, shares stories from two decades at the helm of the first biotech company to develop and take genome editing, using zinc finger nucleases, into the clinic.
…
continue reading
20 episoder
Del
